Journal
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
Volume 24, Issue -, Pages 285-295Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.jgar.2020.12.025
Keywords
Antibiotic resistance; Antibiotic alternative; Antisense oligonucleotide; Short interfering RNA; Monoclonal antibody; Phage therapy
Categories
Ask authors/readers for more resources
Antibiotic resistance is a major healthcare challenge of the 21st century, leading to the exploration of alternative therapies. Among these, antimicrobial oligonucleotides, monoclonal antibodies, and phage therapy stand out as potential solutions for long-term success.
Antibiotic resistance is projected to be one of the greatest healthcare challenges of the 21st century. As the efficacy of these critical drugs wanes and the discovery of new antibiotics stagnates, exploration of alternative therapies could offer a much needed solution. Although numerous alternative therapies are currently under investigation, three in particular appear poised for long-term success, namely antimicrobial oligonucleotides, monoclonal antibodies and phage therapy. Antimicrobial oligonucleotides could conceivably offer the greatest spectrum of activity while having the lowest chance of unrecoverable resistance. Bacteriophages, while most susceptible to resistance, are inexhaustible, inexpensive and exceptionally adept at eliminating biofilm-associated infections. And although monoclonal antibodies may have limited access to such recalcitrant bacteria, these agents are uniquely able to neutralise exotoxins and other diffusible virulence factors. This comparative review seeks to illuminate these promising therapies and to encourage the scientific and financial support necessary to usher in the next generation of infectious disease treatment. (c) 2021 The Author. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available